No ownership or control links for GAO WEI R are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is GAO WEI R's risk level?

WhiteIntel flags GAO WEI R as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does GAO WEI R appear across sources?

GAO WEI R is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

■

GAO WEI R

Name: GAO WEI R — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, GAO WEI R, Company, US

Low

CompanyUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

At a glance

Dimensions on file

Subsidiaries: 1

/02

Key facts

Risk signal

Low

Risk

GAO WEI R is a Company registered in US resolved across 1 source in the WhiteIntel corporate-ownership graph.

/03

Ownership & control

Owners / controllers

None in current sources.

Holdings / subsidiaries

GAO WEI R
- CASI PHARMACEUTICALS HOLDINGS, INC.· officer· via SEC EDGAR

/04

Directorship network

11 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

CASI PHARMACEUTICALS HOLDINGS, INC.

FOLINSBEE THOMASdirector
ZENG XUEBOdirector
WANG CHUNHUAofficer
HUANG HAIofficer
QIAN KUNofficer
ZUKIWSKI ALEXANDER Aofficer
HUANG JAMESdirector
WU ALEXdirector
HE WEI-WUdirector
HE WEI-WUtenpercentowner
KREBS-POHL BARBARA HELENE HANNELOREdirector

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on GAO WEI R. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Loading tips…